Search results
Results from the WOW.Com Content Network
236 Neoplasm of uncertain behavior of genitourinary organs; 237 Neoplasm of uncertain behavior of endocrine glands and nervous system. 237.0 Pituitary gland and craniopharyngeal duct. Pituitary adenoma; 237.7 Neurofibromatosis; 238 Neoplasm of uncertain behavior of other and unspecified sites and tissues 238.4 Polycythemia vera
A neoplasm (/ ˈ n iː oʊ p l æ z əm, ˈ n iː ə-/) [1] [2] is a type of abnormal and excessive growth of tissue. The process that occurs to form or produce a neoplasm is called neoplasia . The growth of a neoplasm is uncoordinated with that of the normal surrounding tissue, and persists in growing abnormally, even if the original trigger ...
The International Classification of Diseases for Oncology (ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases.
An endocrine gland neoplasm is a neoplasm affecting one or more glands of the endocrine system. [citation needed] Examples include: Adrenal tumor; Pituitary adenoma; The most common form is thyroid cancer. [1] Conditions such as pancreatic cancer or ovarian cancer can be considered endocrine tumors, or classified under other systems.
Aggressive fibromatosis or desmoid tumor is a rare condition.Desmoid tumors are a type of fibromatosis and related to sarcoma, though without the ability to spread throughout the body (metastasize).
MRI of a patient with anaplastic astrocytoma. The WHO classification of tumours of the central nervous system is a World Health Organization Blue Book that defines, describes and classifies tumours of the central nervous system (CNS).
Carcinoma in situ (CIS) is a group of abnormal cells. [1] [2] While they are a form of neoplasm, [3] there is disagreement over whether CIS should be classified as cancer.This controversy also depends on the exact CIS in question (e.g., cervical, skin, breast).
Undifferentiated pleomorphic sarcoma (UPS), also termed pleomorphic myofibrosarcoma, [1] high-grade myofibroblastic sarcoma, and high-grade myofibrosarcoma, [2] is characterized by the World Health Organization (WHO) as a rare, poorly differentiated neoplasm (i.e., an abnormal growth of cells that have an unclear identity and/or cell of origin). [3]